Y, L., Y, X., C, G., Y, Z., J, Z., S, Z., . . . B, W. (2020). Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience. Dove Medical Press.
Style de citation Chicago (17e éd.)Y, Li, et al. Comparative Treatment Patterns and Outcomes of Fulvestrant Versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience. Dove Medical Press, 2020.
Style de citation MLA (8e éd.)Y, Li, et al. Comparative Treatment Patterns and Outcomes of Fulvestrant Versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience. Dove Medical Press, 2020.